Grégory Delattre Email & Phone Number

France

Paris, Île-De-France, France

Driving European Markets potfolio profitability: - Strategic Portfolio Planning and Prioritization- P&L Optimization- Go-to-market model definition Spearheading the acceleration of European commercial launches across critical therapeutic areas including Cardiology, Immunology, Oncology, and Hematology, enabling market penetration and revenue growthAs European Market Leadership Team Member, working closely with European Markets SVP to develop and execute data-driven strategies and new commercialization models that align with evolving healthcare trends, regulatory requirements, market access optimization and patient needs across Europe.

Paris, Île-De-France, France

Paris, Île-De-France, France

Managing P&L of France BMS Oncology portfolio (>500M$, 80+ people) France Leadership Team member (COMEX)Cross-functional belonging and engagement culture8 products/indications launches and 4 early access programs

Paris, Île-De-France, France

Sales Force Team Management (60+ people)Oncology Portfolio Sales Management

Paris Area, France

- Cross-functional franchise strategy design (>250M$ franchise)- Brand plan implementation management- P&L management- Co-promotion collaboration

France

Commercial teams manager for Rhône-Alpes / Auvergne region (3 field forces /2 products / 6 indications):- Sales team management- Regional cross-functional lead (Commercial / Medical / Access / Externalrelationships collaboration management)- Regional commercial strategy design

Paris Area, France

Commercial analytics activities for the Immuno-Oncology portfolio (3 products / 9 indications):- Performance reporting: managing the production, optimization and delivery of I-O portfolio performance analyses and reports from sub-national to senior executive levels- Budget and Sales forecasting: leading the cross-functionnal collaboration and production of budget and sales forecasts for the I-O/Haematology Business Unit- New indications launch readiness: working on opportunity assessment and commercial structure organization for future indications/product presentations- Commercial structure optimization: adapting current commercial structure to market events and behaviour evolutions- Market Access and Price negotiation support: collaborating with Market Access teams to support new products price evaluation

Paris, Île-De-France, France

Paris, Île-De-France, France

London, Paris, Stockholm

Commercial Effectiveness experience:- On-site collaboration with in-market Commercial Analytics teams of a Fortune 500 Pharma Company: o Gathering experience in 7 markets head-offices (France, UK, Ireland, Nordics) and 5 therapeutic areas o Strong focus on France Immuno-Oncology (I-O) and Haematology Business Unit, in the interim role of Associate Director, working with Senior Management and providing data-driven insights (advanced analytics, forecasting, performance reporting) to inform and advise on strategic and tactical business decisions o Leading teams supporting data management and analytics activitiesMarketing experience:- Launch Opportunity assessments in EU5 + Nordics markets, conducting market research studies, performing sales forecasting and designing commercial structures in pulmonology and ophthalmology therapeutic areas- Marketing capability building and development of global training programs for marketing talents Sales experience:- Sales force sizing for EU5 + Nordics teams in product launch preparation phase- Territory alignment and call plan optimization for hospital and retail sales force networks

Investigated the role of the Blood-Brain Barrier in the pathogenesis of Neurological diseases and the onset of immunological and clinical symptoms of Multiple Sclerosis

London, United Kingdom

Created a business model for the set up of a new Life Science related company as part of the UCL Entrepreneurship course.

Berlin Area, Germany

Management consulting for the pharmaceutical industry, conducting:- R&D portfolio review- Clinical trial design optimisation- Market Studies- Due Diligence projects

London, United Kingdom

Provided strategy consulting to an expanding London SME wishing to attract investments.

Investigated the involvement of the Dysbindin gene in the pathogenesis of Schizophrenia

Investigated new mechanisms of DNA recombination

Worked as a receptionnist in Andes Hostel, Santiago, Chile

Officer in the French Foreign Legion, Mountain Troops.Training of soldiers in mountain conditions and giving french lessons during missions in the Alps and in Paris.

B.Sc., Engineering-Biology

D.Phil., Neuroscience

M.Sc., Pharmacology